SOUTH PLAINFIELD, N.J. (AP) _ PTC Therapeutics Inc. (PTCT) on Tuesday reported a loss of $143.3 million in its fourth quarter.

The South Plainfield, New Jersey-based company said it had a loss of $2.03 per share.

The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.79 per share.

The biopharmaceutical company posted revenue of $165.2 million in the period.

For the year, the company reported a loss of $523.9 million, or $7.43 per share. Revenue was reported as $538.6 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTCT at https://www.zacks.com/ap/PTCT

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News